Location: New Orleans, LA, United States
Date: December 10 to December 13
LMWH use in pregnancy: The Highlow and the ALPINE trial
Professor Saskia Middeldorp talks about two very important trails were published on LMWH use in pregnancy in 2022. The first one is the Highlow study on the optimal dosing of LMWH in pregnant and post-partum women with the history of VTE. The second one is the ALPINE trial, presented at this year’s ASH congress.